Immunovant (IMVT) PT Raised to $60 at Chardan Capital Markets Nov 12, 2020 04:47PM
Immunovant Announces Closing of $200.0 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Sep 4, 2020 04:01PM
Immunovant (IMVT) Prices 5.27M Share Common Stock Offering at $33/Each Sep 2, 2020 07:34AM
Immunovant Announces Pricing of Public Offering Sep 2, 2020 07:30AM
Immunovant (IMVT) PT Raised to $45 at Chardan Capital Markets Following Data Aug 25, 2020 11:01AM


Aug 13, 2020 08:31AM Immunovant (IMVT) PT Raised to $35 at Chardan Capital Markets
Apr 16, 2020 04:01PM Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 14, 2020 09:28AM Immunovant (IMVT) Announces Pricing of $121.2 Million Public Offering of Common Stock
Apr 14, 2020 09:28AM Immunovant Announces Pricing of $121.2 Million Public Offering
Jan 9, 2020 08:01AM Chardan Capital Markets Starts Immunovant (IMVT) at Buy; Named Top 2020 Pick
Dec 19, 2019 08:00AM Immunovant Sciences Ltd. Closes Transaction with Health Sciences Acquisitions Corporation